The mechanism of the JNK signaling pathway in drug addiction
Journal of Molecular Medicine · 2026-12 · 104 (1)
DOI: 10.1007/s00109-026-02686-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Molecular Medicine, online erschienen am 22.05.2026. Verfasst von Shuang Han und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443000, China. Hauptthemen laut MEDLINE: MAP Kinase Signaling System, Substance-Related Disorders, JNK Mitogen-Activated Protein Kinases. Die Arbeit nennt 84 Literaturangaben. Gefördert von: Hubei Provincial Natural Science Foundation of China, Guiding Project of Scientific and Technological Research Plan of Hubei Provincial Department of Education, Hubei Provincial Natural Science Foundation of China-Yichang Innovation and Development Joint Fund Project.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Drug addiction is a multifactorial neurofunctional disorder influenced by a complex interplay of environmental, biological, and genetic factors. Recent studies have demonstrated that aberrant activation of the c-Jun N-terminal kinase (JNK) signaling pathway plays a critical role in the development of drug addiction. JNK, a member of the mitogen-activated protein kinase (MAPK) family, participates in neural development during embryogenesis and regulates neuronal proliferation and differentiation in adulthood, thereby maintaining the functional integrity of neural stem and progenitor cells and preserving appropriate brain plasticity and homeostasis. By modulating key biological processes such as inflammation, oxidative stress, autophagy, and apoptosis, the JNK signaling pathway regulates neuronal homeostasis and synaptic plasticity and contributes to the molecular mechanisms underlying drug addiction. In addition, JNK signaling influences addiction-related epigenetic regulation by modulating DNA methylation. This review comprehensively analyzes the involvement of the JNK signaling pathway in drug addiction, to broaden current perspectives on addiction research and inform the development of novel therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443000, China.
- Hubei Province Clinical Medical Research Center for Rare Diseases of Nervous System, Yichang, 443000, China.
- Hubei Polytechnic Institute, Xiaogan, 432000, China.
- Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, 443000, China.
- College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
- College of Medicine, Jiaxing University, Jiaxing, 314001, People's Republic of China.
Förderung
- Hubei Provincial Natural Science Foundation of China
- Guiding Project of Scientific and Technological Research Plan of Hubei Provincial Department of Education
- Hubei Provincial Natural Science Foundation of China-Yichang Innovation and Development Joint Fund Project
Zitieren
APA
Han, S., Ye, H., Li, M., Wang, Y., Chen, Y., Zhou, X., & Li, Z. (2026). The mechanism of the JNK signaling pathway in drug addiction. Journal of Molecular Medicine, 104(1). https://doi.org/10.1007/s00109-026-02686-6
Vancouver
Han S, Ye H, Li M, Wang Y, Chen Y, Zhou X, et al. The mechanism of the JNK signaling pathway in drug addiction. Journal of Molecular Medicine. 2026;104(1). doi:10.1007/s00109-026-02686-6
BibTeX
@article{Han2026,
author = {Han, Shuang and Ye, Hongming and Li, Min and Wang, Yuzhu and Chen, Yue and Zhou, Xiaohong and Li, Zicheng},
title = {The mechanism of the JNK signaling pathway in drug addiction},
journal = {Journal of Molecular Medicine},
year = {2026},
volume = {104},
number = {1},
doi = {10.1007/s00109-026-02686-6}
}
EUVIMED